Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Repligen (RGEN) Tops Q3 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus
October 31, 2019 7:39 AM EDTRepligen (NASDAQ: RGEN) reported Q3 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $69.4 million versus the consensus estimate of $66.1 million.
Third Quarter 2019 Highlights
Revenue increased by 40% year-over-year as reported (42% at constant currency) and 28% organically, to $69.4 millionGAAP fully diluted EPS decreased to $0.03 compared to $0.10 for the third quarter of 2018Adjusted (non-GAAP) fully diluted EPS increased to $0.26 compared to $0.18 for the third quarter of 2018REVENUE
Total revenue for the third quarter of 2019 increased to $69.4 million compared to $49.5 million for the third quarter of... More